Nexalin Technology (NXL) Competitors $0.84 -0.01 (-1.64%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$0.84 +0.00 (+0.35%) As of 09/5/2025 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. ICCM, CTSO, SRTS, SURG, PYPD, DXR, CTCX, MDAI, ZYXI, and APTShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include IceCure Medical (ICCM), Cytosorbents (CTSO), Sensus Healthcare (SRTS), SurgePays (SURG), PolyPid (PYPD), Daxor (DXR), Carmell (CTCX), Spectral AI (MDAI), Zynex (ZYXI), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. Its Competitors IceCure Medical Cytosorbents Sensus Healthcare SurgePays PolyPid Daxor Carmell Spectral AI Zynex Alpha Pro Tech IceCure Medical (NASDAQ:ICCM) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership. Which has preferable valuation and earnings, ICCM or NXL? Nexalin Technology has lower revenue, but higher earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIceCure Medical$3.29M18.38-$15.32M-$0.16-6.44Nexalin Technology$170K85.68-$7.61M-$0.76-1.10 Which has more volatility and risk, ICCM or NXL? IceCure Medical has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.68, indicating that its stock price is 268% more volatile than the S&P 500. Do insiders & institutionals hold more shares of ICCM or NXL? 0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to ICCM or NXL? In the previous week, IceCure Medical had 5 more articles in the media than Nexalin Technology. MarketBeat recorded 6 mentions for IceCure Medical and 1 mentions for Nexalin Technology. IceCure Medical's average media sentiment score of 0.81 beat Nexalin Technology's score of -1.00 indicating that IceCure Medical is being referred to more favorably in the media. Company Overall Sentiment IceCure Medical Positive Nexalin Technology Negative Is ICCM or NXL more profitable? IceCure Medical has a net margin of -317.62% compared to Nexalin Technology's net margin of -5,057.14%. IceCure Medical's return on equity of -136.96% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets IceCure Medical-317.62% -136.96% -71.46% Nexalin Technology -5,057.14%-209.20%-186.87% Do analysts recommend ICCM or NXL? IceCure Medical presently has a consensus target price of $2.39, suggesting a potential upside of 131.55%. Nexalin Technology has a consensus target price of $5.00, suggesting a potential upside of 498.01%. Given Nexalin Technology's higher possible upside, analysts plainly believe Nexalin Technology is more favorable than IceCure Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryIceCure Medical beats Nexalin Technology on 9 of the 16 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$14.56M$2.71B$6.64B$9.92BDividend YieldN/A1.58%2.74%4.52%P/E Ratio-1.1023.4427.1526.13Price / Sales85.6842.831,091.77173.41Price / CashN/A44.7726.9459.28Price / Book2.997.186.896.09Net Income-$7.61M$35.06M$199.16M$266.51M7 Day Performance-12.57%0.79%-0.06%0.45%1 Month Performance-10.10%4.66%9.24%5.05%1 Year Performance1.08%58.71%46.61%26.03% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology1.8402 of 5 stars$0.84-1.6%$5.00+498.0%+1.1%$14.56M$170K-1.103Negative NewsShort Interest ↑ICCMIceCure Medical3.3087 of 5 stars$1.06-5.8%$2.39+126.1%+60.9%$61.93M$3.29M-6.5960News CoveragePositive NewsShort Interest ↓CTSOCytosorbents1.8315 of 5 stars$0.95+0.2%$5.50+482.0%-6.3%$59.31M$35.60M-5.56220Gap DownSRTSSensus Healthcare2.2736 of 5 stars$3.47+2.2%$8.00+130.9%-41.5%$56.80M$41.81M-57.5840Gap UpSURGSurgePays2.4594 of 5 stars$2.72+0.6%$9.00+231.5%+98.6%$55.77M$60.88M-1.1040Short Interest ↑PYPDPolyPid2.919 of 5 stars$3.45+3.0%$12.40+259.4%-3.4%$54.68MN/A-0.9080Short Interest ↑DXRDaxor3.33 of 5 stars$11.00-2.5%$25.00+127.3%+27.1%$53.24MN/A0.0037News CoverageShort Interest ↑Gap DownCTCXCarmellN/A$2.54-1.6%N/A+415.3%$53.09M$32.84K0.0014MDAISpectral AI2.3777 of 5 stars$1.97+2.1%$3.50+77.7%+34.8%$52.20M$29.58M-2.8383Positive NewsZYXIZynex2.0948 of 5 stars$1.67+2.1%$4.90+192.7%-81.0%$50.72M$192.35M-1.78770Positive NewsAPTAlpha Pro Tech1.9897 of 5 stars$4.67-2.3%N/A-15.0%$48.91M$58.56M12.62120Short Interest ↓ Related Companies and Tools Related Companies IceCure Medical Alternatives Cytosorbents Alternatives Sensus Healthcare Alternatives SurgePays Alternatives PolyPid Alternatives Daxor Alternatives Carmell Alternatives Spectral AI Alternatives Zynex Alternatives Alpha Pro Tech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXL Stock Alerts